Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia

10.1378/chest.128.6.3854

10.1378/chest.128.6.3784

2005, Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcareassociated pneumonia, 388

10.1378/chest.08-1357

10.1378/chest.127.1.213

10.1016/j.ajem.2008.03.015

10.1016/j.jinf.2007.10.001

10.1111/j.1469-0691.2009.03027.x

10.1111/j.1469-0691.2011.03484.x

10.1016/S1473-3099(10)70032-3

10.1097/QCO.0b013e328329fa4e

10.1016/j.rmed.2012.08.003

10.1111/j.1469-0691.2010.03420.x

10.1001/archinte.167.13.1393

10.1007/s10096-006-0193-0

10.1016/j.idc.2004.08.001

10.1378/chest.126.5.1575

10.1016/j.jhin.2010.09.031

10.1111/j.1469-0691.2011.03757.x

10.1136/thoraxjnl-2011-200630

Yoon, 2010, The clinical and microbial characteristics of healthcare-associated pneumonia, 709

10.1016/S0002-9343(98)00262-9

10.1086/430314

10.1186/1471-2334-11-61